TY  - BOOK
AU  - Ahmad Abdelraheem Ahmad Abdelraheem
AU  - Fouad Mohamed AbuTaleb , 
AU  - Nahla Elsharkawy , 
AU  - Osman Mohamed Mansour , 
TI  - Low bose cytarabine with or without anthracycline in the induction treatment of elderly patients with acute myeloid leukemia / 
PY  - 2011///
CY  - Cairo : 
PB  - Ahmad Abdelraheem Ahmad Abdelraheem , 
KW  - Acute myelogenous leukemia
KW  - Elderly
KW  - Low- dose
N1  - Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Oncology-Medical; Issued also as CD
N2  - Acute myelogenous leukemia is a disease of the elderly with median age at diagnosis 60 years, despite an improved molecular understanding of AML, treatment has been largely unsuccessful in the population age 60 and older with most patients dying within one year of diagnosis. To compare the outcome of elderly AML patients receiving low dose cytarabine (LDAC) plus doxorubicin versus low dose cytarabine to identify which one is more suitable for elderly AML patient regarding response rate
ER  -